▲ BUY
7
/ 10
Conviction
$ Value
$8K
Shares
20,000
Price
$0
Filed
Aug 19
▶ Why this score? (7/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Finney Kevin
Title
—
CIK
0002053381
Roles
Director
Transaction Details
Transaction Date
2025-07-28
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
78,897
Footnotes
This transaction is being reported late due to an administrative oversight.
Filing Info
Finney Kevin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-08-15 | VXRT | ▲ | $18K |
| 2025-08-15 | VXRT | ▲ | $18K ★ |
| 2025-07-30 | VXRT | ▲ | $10K |
| 2025-07-28 | VXRT | ▲ | $8K |
| 2025-07-25 | VXRT | ▲ | $8K |
| 2025-07-17 | VXRT | ▲ | $302 |
| 2025-06-13 | VXRT | A | $0 |
| 2025-06-13 | VXRT | A | $0 |
Other Insiders at VXRT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Lo Steven
President, Chief Exec Officer
|
— | — | 2026-03-24 |
|
Tucker Sean
SVP, Chief Scientific Officer
|
— | — | 2026-03-28 |
|
Cummings James F.
Chief Medical Officer
|
— | — | 2026-03-28 |
|
Berg Edward B
SVP, General Counsel
|
— | — | 2026-03-24 |
|
Grasman Jeroen Nicolaas
Chief Financial Officer
|
— | — | 2026-03-16 |